Monoclonal gammopathy plus positive amyloid biopsy does not always equal AL amyloidosis-Reference-Cited by-同舟云学术

Monoclonal gammopathy plus positive amyloid biopsy does not always equal AL amyloidosis

Published:2019-02-27 Issue:5 Volume:94 Page:
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Sidiqi M Hasib¹^ORCID,Dasari Surendra²,McPhail Ellen D.³,Buadi Francis K.¹,Warsame Rahma¹^ORCID,Lacy Martha Q.¹,Dingli David¹,Gonsalves Wilson I.¹^ORCID,Kapoor Prashant¹,Kourelis Taxiarchis¹^ORCID,Leung Nelson¹⁴^ORCID,Muchtar Eli¹,Grogan Martha⁵,Lust John A.¹,Kumar Shaji¹,Kyle Robert A.¹,Rajkumar Vincent S.¹^ORCID,Gertz Morie¹^ORCID,Dispenzieri Angela¹^ORCID

Affiliation:

1. Division of Hematology, Department of Internal MedicineMayo Clinic Rochester Rochester Minnesota

2. Department of Health Sciences ResearchMayo Clinic Rochester Rochester Minnesota

3. Department of Laboratory Medicine and PathologyMayo Clinic Rochester Rochester Minnesota

4. Division of Nephrology and HypertensionMayo Clinic Rochester Rochester Minnesota

5. Department of Cardiovascular MedicineMayo Clinic Rochester Rochester Minnesota

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.25440

Reference6 articles.

1. Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation inalpha2‐macroglobulinandtau: A population‐based autopsy study

2. Epidemiology of the plasma-cell disorders

3. Monoclonal gammopathy of undetermined significance in systemic transthyretin amyloidosis (ATTR)

4. Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3

5. Serum Free Light Chain Specificity and Sensitivity: A Reality Check

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing Renal Amyloidosis Care: The Role of Modern Diagnostic Techniques with the Potential of Enhancing Patient Outcomes;International Journal of Molecular Sciences;2024-05-28

2. Recommandations 2024 de l’Intergroupe francophone du myélome sur la prise en charge des gammapathies monoclonales de signification indéterminée;Hématologie;2024-01-01

3. AL amyloidosis: Singapore Myeloma Study Group consensus guidelines on diagnosis, treatment and management;Annals of the Academy of Medicine, Singapore;2023-11-29

4. Monoclonal Gammopathy of Undetermined Significance in Patients With Transthyretin Amyloidosis (ATTR): Analysis Using the iStopMM Criteria;Clinical Lymphoma Myeloma and Leukemia;2023-03

5. Diagnosis and treatment of AL amyloidosis in 2022;Canadian Hematology Today;2022-03-01